Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Joel, Joelsson"'
Autor:
Tove Wästerlid, Sverker Hasselblom, Joel Joelsson, Caroline E. Weibull, Georgios Rassidakis, Birgitta Sander, Karin E. Smedby
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/4879502fd1c34cdeb5b0d9e3e647bdef
Autor:
Nadine G. Andersson, Mathias Rathe, Ingolf Mølle, Kirsten Brunswig Jarvis, Marianne Hoffmann, Anu Huurre, Joel Joelsson, Birgitte Klug Albertsen, Olli Lohi, Satu Långström, Ulrik Overgaard, Sonata Saulyte Trakymiene, Kaisa Vepsäläinen, Hartmut Vogt, Susanna Ranta
Publikováno v:
Andersson, N G, Rathe, M, Mølle, I, Jarvis, K B, Hoffmann, M, Huurre, A, Joelsson, J, Albertsen, B K, Lohi, O, Långström, S, Overgaard, U, Saulyte Trakymiene, S, Vepsäläinen, K, Vogt, H & Ranta, S 2022, ' A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia (ALL) in the Nordic and Baltic countries : Different practices of assessment and management ', British Journal of Haematology, vol. 199, no. 1, pp. 117-121 . https://doi.org/10.1111/bjh.18397
British journal of haematology, Hoboken : Wiley, 2022, first on line, p. [1-5]
British journal of haematology, Hoboken : Wiley, 2022, first on line, p. [1-5]
Patients undergoing treatment for acute lymphoblastic leukaemia (ALL) are at risk of coagulopathy, especially thromboembolism. We conducted a survey on practices in the assessment and management of coagulopathy during the new ALLTogether protocol in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45395d7c392f8f5d50780d3605403a86
https://pure.au.dk/portal/da/publications/a-survey-on-thromboprophylaxis-and-coagulation-assessment-in-children-and-young-adults-with-acute-lymphoblastic-leukaemia-all-in-the-nordic-and-baltic-countries(3513b88b-9b99-4f49-a15d-a022adb568ef).html
https://pure.au.dk/portal/da/publications/a-survey-on-thromboprophylaxis-and-coagulation-assessment-in-children-and-young-adults-with-acute-lymphoblastic-leukaemia-all-in-the-nordic-and-baltic-countries(3513b88b-9b99-4f49-a15d-a022adb568ef).html
Autor:
Jacob Nersting, Nina Toft, Linea Natalie Toksvang, Thomas Frandsen, Stine Nygaard Nielsen, Laimonas Griskevicius, Signe Sloth Mogensen, Riitta Niinimäki, Joel Joelsson, Ulrik Malthe Overgaard, Olafur G. Jonsson, Kjeld Schmiegelow, Jonas Abrahamsson, Cecilie Utke Rank, Kathrine Grell, Arja Harila-Saari, Petter Quist-Paulsen, Goda Vaitkevičienė, Liv Andrés-Jensen
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:911-917
Osteonecrosis is a burdensome treatment-related toxicity that is mostly diagnosed during or soon after 6-mercaptopurine (6MP)/methotrexate (MTX) maintenance therapy for acute lymphoblastic leukemia (ALL), possibly indicating a pathogenic role of thes
Autor:
Joel, Joelsson, Tove, Wästerlid, Richard, Rosenquist, Lasse Hjort, Jakobsen, Tarec C, El-Galaly, Karin E, Smedby, Sandra, Eloranta
Publikováno v:
Blood advances. 6(8)
Considering treatment changes and an improved prognosis of non-Hodgkin lymphoma (NHL) over time, knowledge regarding long-term health outcomes, including late effects of treatment, has become increasingly important. We report on time trends of second
Autor:
Caroline E. Weibull, Karin E. Smedby, Joel Joelsson, Sverker Hasselblom, Tove Wästerlid, Georgios Rassidakis, Birgitta Sander
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-5 (2021)
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-5 (2021)
Autor:
Linea Natalie, Toksvang, Liv, Andrés-Jensen, Cecilie Utke, Rank, Riitta, Niinimäki, Jacob, Nersting, Stine Nygaard, Nielsen, Signe Sloth, Mogensen, Arja, Harila-Saari, Jonas, Abrahamsson, Joel, Joelsson, Ulrik Malthe, Overgaard, Petter, Quist-Paulsen, Laimonas, Griškevičius, Ólafur Gisli, Jónsson, Goda, Vaitkevičienė, Thomas Leth, Frandsen, Nina, Toft, Kathrine, Grell, Kjeld, Schmiegelow
Publikováno v:
Cancer chemotherapy and pharmacology. 88(5)
Osteonecrosis is a burdensome treatment-related toxicity that is mostly diagnosed during or soon after 6-mercaptopurine (6MP)/methotrexate (MTX) maintenance therapy for acute lymphoblastic leukemia (ALL), possibly indicating a pathogenic role of thes
Autor:
Nicola Vianelli, Francesca Palandri, Nicola Polverelli, Roberto Stasi, Joel Joelsson, Eva Johansson, Marco Ruggeri, Francesco Zaja, Silvia Cantoni, Angelo Emanuele Catucci, Anna Candoni, Enrica Morra, Magnus Björkholm, Michele Baccarani, Francesco Rodeghiero
Publikováno v:
Haematologica, Vol 98, Iss 6 (2013)
The treatment of choice in steroid-resistant immune thrombocytopenia is still controversial due to the recent advent of new drugs (anti-CD20 antibodies and thrombopoietin mimetics) that have encouraged a generalized tendency to delay splenectomy. Con
Externí odkaz:
https://doaj.org/article/f606448ed33d480f90095559c34d19e4
Autor:
Maria Ljungqvist, Sara Harrysson, Björn E. Wahlin, Kristina Sonnevi, Per Bernell, Tove Wästerlid, Joel Joelsson
Publikováno v:
Blood. 138:4587-4587
INTRODUCTION Patients with high-risk aggressive B-cell lymphoma exhibit poor survival after R-CHOP-like immunochemotherapy. More intensive regimens yield higher rates of remission but also of complication, which have hindered their use, particularly
Autor:
Lucia Ahlberg, Hege Garelius, Erik Hulegårdh, Andreea Moicean, Piotr Kozlowski, Karin Karlsson, Emma Bergfelt Lennmyr, Antonio Santamaria Izarra, Beata Tomaszewska-Toporska, Anna Lübking, Helene Hallböök, Joel Joelsson
Publikováno v:
European Journal of Haematology
Objectives As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results of clinical trials need to relate to standard of care. Methods We used the population-based Swedish ALL Registry to evaluate characteristics, treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d45ad365de408231994163506c9ed67e
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-390495
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-390495
Autor:
Joel Joelsson, Roberto Stasi, Nicola Polverelli, Eva Johansson, Silvia Cantoni, Marco Ruggeri, Michele Baccarani, Nicola Vianelli, Magnus Björkholm, Francesca Palandri, Enrica Morra, Anna Candoni, Francesco Zaja, Francesco Rodeghiero, Angelo Emanuele Catucci
Background. The treatment of choice in steroid-resistant ITP is still controversial, due to the recent advent of new drugs (anti-CD20 and thrombopoietin mimetics) which have encouraged a generalized tendency to delay splenectomy. Consequently, the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304002a0442df4dd4c7cb20bcbf82632
https://hdl.handle.net/11379/569800
https://hdl.handle.net/11379/569800